Growth hormone treatment affects brain neurotransmitters and thyroxine

Clinical Endocrinology

Volumn 44, Issue 3, 1996, Pages 319-324

  Burman, P ^a   Hetta, J ^a   Wide, L ^a   Mansson J E ^b   Ekman, R ^b   Karlsson, F A ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; BETA ENDORPHIN; GLUTAMIC ACID; GLYCINE; HOMOVANILLIC ACID; HUMAN GROWTH HORMONE; NEUROTRANSMITTER; RECOMBINANT GROWTH HORMONE; THYROXINE;

ADULT; ARTICLE; BRAIN; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; MALE; MOOD; PRIORITY JOURNAL;

EID: 0030022979     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.617439.x     Document Type: Article

References (33)

1. Almqvist, O., Thorén, M., Sääf, M. & Eriksson, O. (1986) Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: a pilot study. Psychoneuroendocrinology, 11, 347-352.
2. Bauer, M.S. & Whybrow, P.C. (1988) Thyroid hormones and the central nervous system in affective illness: interactions that may have clinical significance. Integrated Psychiatry, 6, 75-100.
3. Bengtsson, B.-Å., Edén, S., Lönn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tölli, J., Sjöström, L. & Isaksson, O.G.P. (1993) Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. Journal of Clinical Endocrinology and Metabolism, 76, 309-317.
4. Blennow, K., Wallin, A., Gottfries, C.G., Månsson, J.-E. & Svennerholm, L. (1993a) Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid. Journal of Neural Transmission (P-D Sect.), 5, 5-15.
5. Blennow, K., Wallin, A., Gottfries, C.G., Karlsson, I., Månsson, J.-E., Skoog, I., Wikkelsö, C. & Svennerholm, L. (1993b) Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age. European Neuropsychopharmacology, 3, 55-61.
6. Bramnert, M., Ekman, R., Larsson, I. & Thorell, J.I. (1982) Characterization and application of a radioimmunoassay for β-endorphin using an antiserum with negligible cross-reactivity against β-lipotropin. Regulatory Peptides, 5, 65-75.
7. Burrnan, P., Broman, J.E., Hetta, J., Wiklund, I., Erfurth, E.M., Hägg, E. & Karlsson, F.A. (1995) Quality of life in adults with growth hormone deficiency. Response to treatment with recombinant human growth hormone in a placebo controlled 21 months trial. Journal of Clinical Endocrinology and Metabolism, in press.
8. Dean, H.J., McTaggart, T.L., Fish, D.G. & Friesen, H.G. (1985) The educational, vocational and marital status of growth hormone deficient adults treated with growth hormone during childhood. American Journal of Diseases in Children, 139, 1105-1110.
9. Gardner, D. (1995) Synaptic transmission. In Neuroscience in Medicine (ed. Conn PM), pp. 75-114. Jb Lippincott Company, Philadelphia.
10. Goldsmith, R.F., Earl, J.W. & Cunningham, A.M. (1987) Determination of γ-aminobutyric acid and other amino acids in cerebrospinal fluid of pediatric patients by reversed-phase liquid chromatography. Clinical Chemistry, 33, 1736-1740.
11. Goodwin, F.K., Prange, A.J., Post, R.M., Muscettola, G. & Lipton, M.A. (1982) Potentiation of antidepressant effects by triodothyronine in tricyclic nonresponders. American Journal of Psychiatry, 139, 34-38.
12. Grunfeld, C., Sherman, B.M. & Cavalieri, R.R. (1988) The acute effects of human growth hormone administration on thyroid function in normal men. Journal of Clinical Endocrinology and Metabolism, 67, 1111-1114.
13. Hyman, S.E. & Nestler, E.J. (1993) In The Molecular Foundations of Psychiatry (eds S.E. Hyman & E.J. Nestler), pp. 56-135 American Psychiatric Press, Inc, Washington DC.
14. Johansson, J.-O., Larsson, G., Elmgren, A., Hynsjö, L., Lindahl, A., Lundberg, P.-A., Isaksson, O., Lindstedt, S. & Bengtsson, B.-A. (1995) Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology, 61, 57-66.
15. Jørgensen, J.O.L., Pedersen, S.A., Laurberg, P., Weeke, J., Skakkebaek, N.E. & Christiansen, J.S. (1989) Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. Journal of Clinical Endocrinology and Metabolism, 69, 1127-1132.
16. Jorgensen, J.O.L., Møller, J., Møller N., Lauritzen, T. & Christiansen, J.S. (1990) Pharmacological aspects of growth hormone replacement therapy, route, frequency and timing of administration. Hormone Research, 33(Suppl 4), 77-82.
17. Kierkegaard, C. & Faber, J. (1991) Free thyroxine and 3,3′,5′-triiodothyronine levels in cerebrospinal fluid in patients with endogenous depression. Acta Endocrinologica (Copenhagen), 124, 166-172.
18. Koenig, R.J., Brent, G.A., Warne, R.L., Larsen, P.R. & Moore, D.D. (1987) Thyroid hormone receptor binds to a site in the rat growth hormone promotor required for induction by thyroid hormone. Proceedings of the National Academy of Sciences, USA, 84, 5670-5674.
19. Lai, Z., Emtner, M., Roos, P. & Nyberg, F. (1991) Characterization of putative growth hormone receptors in human choroid plexus. Brain Research, 546, 222-226.
20. Leonard, J.L., Silva, J.E., Kaplan, M.M., Mellen, S.A., Visser, T.J. & Larsen, P.R. (1984) Acute posttranscriptional regulations of cerebrocortical and pituitary iodothyronine 5′deiodinase by thyroid hormone. Endocrinology, 114, 998-1004.
21. McGauley, G.A. (1989) Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatrica Scandinavica, 356 (Suppl.), 70-72.
22. Nishikawa, M., Inada, M., Naito, K., Ishii, H., Tanaka, K., Mashio, Y., Nakao, K., Nakai, Y., Udaka, F. & Imura, H. (1981) 3,3′,5′-triiodothyronine (reverse T3) in human cerebrospinal fluid. Journal of Clinical Endocrinology and Metabolism, 53, 1030-1035.
23. Risby, E.D., Hsiao, J.K., Sunderland, T., Agren, H., Rudorfer, M.V. & Potter, W.Z. (1987) The effects of antidepressants on the cerebrospinal fluid homovanillic acid/5-hydroxyindoleacetic acid ratio. Clinical Pharmacology and Therapeutics, 42, 547-554.
24. Rosén, T., Wirén, L., Wilhelmsen, L., Wiklund, I. & Bengtsson, B.-Å. (1994) Decreased psychological well-being in adult patients with growth hormone deficiency. Clinical Endocrinology, 40, 111-116.
25. Sato, T., Suzuki, Y., Taketani, T., Ishiguro, K., Masuyama, T., Takata, Sano, M., Kawashima, H., Koizumi, S. & Nakajima, H. (1977) Enhanced peripheral conversion of thyroxine to triiodothyronine during hGH therapy in GH deficient children. Journal of Clinical Endocrinology and Metabolism, 45, 324-329.
26. Schreiber, G., Aldred, A.R., Jaworoski, A., Nilsson, C., Achen, M.G. & Segal, M.B. (1990) Thyroxin transport from blood to brain via transthyretin synthesis in choroid plexus. American Journal of Physiology, 27, R338-R345.
27. Svensson, A., Pileblad, E. & Carlsson, M. (1991) A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CCPene with regard to dopamine turnover and locomotor stimulatory properties in mice. Journal of Neural Transmission (Gen. Sect.), 85, 117-129.
28. Thompson, P., Burman, K.D., Wright, F.D., Potter, M.W. & Wartofsky, L. (1982) Iodothyronine levels in human cerebrospinal fluid. Journal of Clinical Endocrinology and Metabolism, 54, 653-655.
29. Vaerøy, H. & Nyberg, F. (1993) Endogenous opioid peptides. substance P, calcitonin gene-related peptide and their relation to fibromyalgia. In Progress in Fibromyalgia and Myofascial Pain (eds H. Vaerøy & H. Merskey), pp. 75-91. Elsevier Science Publishers B.V.
30. Wheatley, D. (1972) Potentiation of amitriptyline by thyroid hormone. Archives of General Psychiatry, 26, 229-233.
31. Whybrow, P.C. (1991) Behavioral and psychiatric aspects of hypothyroidism. In Werner and Ingbar's The Thyroid. A Fundamental and Clinical Text. 6th edition. (eds L.E. Braverman & R. D. Utiger), pp. 1078-1083. J. B. Lippincott Company, Philadephia.
32. Wilson, I.C., Prange, A.J., McClane, T.K., Rabon, A.M. & Lipton, M.A. (1970) Thyroid-hormone enhancement of imipramine in non retarded depressions. New England Journal of Medicine, 282, 1063-1067.
33. Wolf, M., Ingbar, S.H. & Moses, A.C. (1989) Thyroid hormone and growth hormone interact to regulate insulin-like growth factor-1 messenger ribonucleic acid and circulating levels in the rat. Endocrinology, 125, 2905-2914.